Atria Investments’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.88M Sell
29,825
-3,156
-10% -$221K 0.02% 789
2026
Q1
$2.49M Buy
32,981
+2,943
+10% +$210K 0.03% 612
2025
Q4
$1.85M Buy
30,038
+5,716
+24% +$336K 0.02% 757
2025
Q3
$1.43M Buy
24,322
+3,506
+17% +$204K 0.02% 869
2025
Q2
$1.21M Buy
20,816
+5,066
+32% +$286K 0.01% 942
2025
Q1
$782K Buy
15,750
+4,145
+36% +$212K 0.01% 1118
2024
Q4
$519K Sell
11,605
-3,031
-21% -$144K 0.01% 1304
2024
Q3
$703K Buy
14,636
+290
+2% +$14K 0.01% 1157
2024
Q2
$730K Buy
+14,346
New +$785K 0.01% 1104
2023
Q2
– Sell
-18,725
Closed -$1.38M – 867
2023
Q1
$1.38M Buy
18,725
+3,201
+21% +$247K 0.03% 680
2022
Q4
$1.13M Sell
15,524
-1,433
-8% -$113K 0.02% 717
2022
Q3
$1.41M Buy
16,957
+3,251
+24% +$280K 0.03% 600
2022
Q2
$1.09M Buy
13,706
+1,494
+12% +$145K 0.02% 721
2022
Q1
$1.27M Buy
+12,212
New +$1.01M 0.02% 745
2020
Q1
– Sell
-4,416
Closed -$212K – 974
2019
Q4
$212K Buy
+4,416
New +$213K 0.01% 1130

Other funds holding NTR

Atria Investments's NTR Position: Q2 2026 in Review

Atria Investments reduced its Nutrien (NTR) stake by 9.6% in Q2 2026, selling an estimated $221K and leaving 29,825 shares worth $1.88M. The position accounts for 0.02% of the portfolio, ranked #789.

Atria Investments first reported a position in NTR in Q4 2019 and has held it in 15 quarters since. The position peaked at $2.49M in Q1 2026. 734 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Atria Investments held 29,825 shares of Nutrien worth $1.88M as of Q2 2026.
  • Atria Investments sold 3,156 Nutrien shares in Q2 2026, an estimated $221K.
  • Nutrien made up 0.02% of Atria Investments's portfolio in Q2 2026, its #789 holding.
  • Atria Investments first reported a position in Nutrien in Q4 2019 and has held it in 15 quarters since.
  • Atria Investments's Nutrien position peaked at $2.49M in Q1 2026.
  • 734 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.